1309 related articles for article (PubMed ID: 27256096)
1. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
[TBL] [Abstract][Full Text] [Related]
2. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
[TBL] [Abstract][Full Text] [Related]
3. Herpes Virus Infections During Treatment With Etanercept in Juvenile Idiopathic Arthritis.
Nicolai R; Cortis E; Ravà L; Bracaglia C; Pardeo M; Insalaco A; Buonuomo PS; Tozzi AE; De Benedetti F
J Pediatric Infect Dis Soc; 2016 Mar; 5(1):76-9. PubMed ID: 26908493
[TBL] [Abstract][Full Text] [Related]
4. Varicella in a pediatric heart transplant population on nonsteroid maintenance immunosuppression.
Dodd DA; Burger J; Edwards KM; Dummer JS
Pediatrics; 2001 Nov; 108(5):E80. PubMed ID: 11694664
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy for varicella and herpes zoster.
Arvin AM
Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
[TBL] [Abstract][Full Text] [Related]
6. Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Nimmrich S; Horneff G
Rheumatol Int; 2015 Mar; 35(3):465-70. PubMed ID: 25583050
[TBL] [Abstract][Full Text] [Related]
7. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment.
Snoeck R; Andrei G; De Clercq E
Drugs; 1999 Feb; 57(2):187-206. PubMed ID: 10188760
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
Wutzler P
Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
[TBL] [Abstract][Full Text] [Related]
9. Varicella-zoster virus infection in Romanian children infected with the human immunodeficiency virus.
Leibovitz E; Cooper D; Giurgiutiu D; Coman G; Straus I; Orlow SJ; Lawrence R
Pediatrics; 1993 Dec; 92(6):838-42. PubMed ID: 7901834
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.
Pileggi GS; de Souza CB; Ferriani VP
Arthritis Care Res (Hoboken); 2010 Jul; 62(7):1034-9. PubMed ID: 20235203
[TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus infections in immunocompromised patients - a single centre 6-years analysis.
Wiegering V; Schick J; Beer M; Weissbrich B; Gattenlöhner S; Girschick HJ; Liese J; Schlegel PG; Eyrich M
BMC Pediatr; 2011 May; 11():31. PubMed ID: 21569228
[TBL] [Abstract][Full Text] [Related]
12. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
15. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.
Onozawa M; Hashino S; Haseyama Y; Hirayama Y; Iizuka S; Ishida T; Kaneda M; Kobayashi H; Kobayashi R; Koda K; Kurosawa M; Masauji N; Matsunaga T; Mori A; Mukai M; Nishio M; Noto S; Ota S; Sakai H; Suzuki N; Takahashi T; Tanaka J; Torimoto Y; Yoshida M; Fukuhara T
Biol Blood Marrow Transplant; 2009 Jun; 15(6):724-9. PubMed ID: 19450757
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients.
König C; Kleber M; Reinhardt H; Knop S; Wäsch R; Engelhardt M
Ann Hematol; 2014 Mar; 93(3):479-84. PubMed ID: 24318541
[TBL] [Abstract][Full Text] [Related]
17. Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era.
Pandya A; Wasfy S; Hébert D; Allen UD
Pediatr Transplant; 2001 Jun; 5(3):153-9. PubMed ID: 11422816
[TBL] [Abstract][Full Text] [Related]
18. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to varicella-zoster virus infections.
Whitley RJ
J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Steer CB; Szer J; Sasadeusz J; Matthews JP; Beresford JA; Grigg A
Bone Marrow Transplant; 2000 Mar; 25(6):657-64. PubMed ID: 10734301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]